Pembrolizumab (anti-PD-1)
Catalog No.A2005 Synonyms: MK-3475, lambrolizumab
For research use only.
Not for use in humans.

Pembrolizumab (anti-PD-1) is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD.
Cited by 5 publications
Quality Control
Choose Selective PD-1/PD-L1 Inhibitors
Biological Activity
Description | Pembrolizumab (anti-PD-1) is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD. | |
---|---|---|
Targets |
|
|
In vivo | In addition to Melanoma and Lung carcinoma, pembrolizumab has also demonstrated efficacy in other advanced solid tumors and hematologic malignancies. Pembrolizumab had an acceptable side-effect profile and showed antitumor activity in patients with advanced non-small-cell lung cancer[2]. |
Protocol
Cell Research: |
- Collapse
|
---|---|
Animal Research: |
- Collapse
|
Product Details
CAS No. | 1374853-91-4 |
---|---|
Formulation | PBS buffer, pH 7.2 |
Isotype | Human IgG4 |
Source | CHO cells |
Storage | Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
Tech Support
If you have any other enquiries, please leave a message.
Frequently Asked Questions
-
Question 1:
How to store the antibody?
-
Answer:
Store the undiluted solution at 4 °C in the dark. Freezing antibodies can result in a loss of activity caused by the freezing/thawing process. Diluting antibodies to working concentrations and storing at 4°C for more than a day should be avoided. Additionally, make sure to keep the antibody sterile. Under these storage conditions, your antibodies should remain active for up to one year and oftentimes longer.